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NanobiomaterialsThe design of 3D constructs with adequate properties to instruct and guide cells both in vitro and in vivo is one of
the major focuses of tissue engineering. Successful tissue regeneration depends on the favorable crosstalk be-
tween the supporting structure, the cells and the host tissue so that a balanced matrix production and degrada-
tion are achieved. Herein, the major occurring events and players in normal and regenerative tissue are
overviewed. These have been inspiring the selection or synthesis of instructive cues to include into the 3D con-
structs.We further highlight the importance of amultiscale perception of the range of features that can be includ-
ed on the biomimetic structures. Lastly, we focus on the current and developing tissue-engineering approaches
for the preparation of such 3D constructs: top-down, bottom-up and integrative. Bottom-up and integrative ap-
proaches present a higher potential for the design of tissue engineering devices with multiscale features and
higher biochemical control than top-down strategies, and are the main focus of this review.
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Tissue engineering aims to restore the loss of tissue and organ's func-
tionality resulting from injury, aging or disease (Lanza et al., 2011). Bio-
materials, cells and bioactive factors are commonly considered the key
elements needed for the preparation of 3D tissue engineered constructs
for the regeneration of those damaged tissues (Hench and Polak, 2002;
Langer and Vacanti, 1993). Those act primarily as supportive and infor-
mative platforms that guide cell behavior. The physicochemical proper-
ties of those devices affect cell adhesion, proliferation, differentiation
and matrix synthesis. Upon implantation, their properties also dictate
host tissue response: inﬂammatory and immune responses (Franz
et al., 2011). Moreover, the cellular and matrix compositions of the
injured tissue will inﬂuence the cell responses in the construct. The fur-
ther crosstalk between the construct and the host tissuewill thus deﬁne
the provisional micro/nano-environment, dictating cell behavior and
consequently tissue fate: failed healing, repair or regeneration — Fig. 1
(Sephel and Woodward, 2001).
This repairing/regenerative micro/nano-environment is regulated
by several cell types, matrix proteins, growth factors and cytokines.
Only an adequate balance between new matrix deposition and matrix
degradation allows the achievement of a successfully regenerated tissue
that is identical to the original one.
Tissue engineering has focused on thedesign of 3Ddevices to promote
the regeneration of several types of tissues, e.g.: skin (Groeber et al.,
2011), cartilage (Mano and Reis, 2007), bone (Healy and Guldberg,
2007), tendon (Hampson et al., 2008), and cardiac tissue (Chiu and
Radisic, 2013).
The ideal features of the 3D structures have been evolving with in-
creasing understanding of cell–material interactions both in vitro and
in vivo (Custodio et al., 2014a; Hench and Polak, 2002). The intent of
the current paradigm of the construct is to provide instructive cues for
cellular activation and guidance. Besides demanding an adequate cell
instruction regarding migration, proliferation and differentiation, the
ideal construct also requires other generic characteristics, such as suit-
able nutrients and metabolite diffusion, regulated degradation proﬁle
and patient-customization. The design of 3D substrates fulﬁlling all re-
quirements is still very challenging (Mano, 2015; Oliveira and Mano,Fig. 1. Successful tissue regeneration depends on favorable crosstalk and multidirectional instr
and degradation.
Please cite this article as: Oliveira, S.M., et al., Towards the design of 3Dmu
and trends, Biotechnol Adv (2015), http://dx.doi.org/10.1016/j.biotechadv2014). It demands themanagement and understanding of multiple var-
iables that are distributed along all length-scales and affect cell behavior
in vitro and in vivo. Processing techniques are still evolving and promise
increasing control on the multiscale and spatial–temporal features of
the constructs. Herein, we begin summarizing the major occurring
events and features in the normal and regenerative cell environment
(niche) as design inspirations for instructive biomaterials. We highlight
the importance of a multiscale understanding of the range of properties
that can be included on the substrates. Lastly, we overview the current
and expected tissue engineering approaches for the preparation of 3D
constructs: top-down, bottom-up and integrative approaches.
2. Tissue/cell niches as regenerative inspiration for biomaterials
design
The stem cell niches are dynamic and complex structures where di-
verse biochemical, physical, metabolic, inﬂammatory, and cellular-
derived cues bi-directionally and reciprocally interact with several
local cells and stem cells — Table 1.
The niches are responsible for modulating stem cell behavior, which
is crucial for the maintenance of tissue homeostasis (Jones andWagers,
2008; Lane et al., 2014; Li and Xie, 2005; Moore and Lemischka, 2006;
Schoﬁeld, 1977). The ability of the stem cells to self-renew and differen-
tiate is orchestrated by the spatiotemporal presentation of niche's cues
and the dialogs occurringwith several cell types. Both niches and tissues
are multiscale and complex systems where smaller units interact origi-
nating larger cellular structures. The secreted factors, the physical cues,
the extracellular matrix and other cells interact with the cell surface re-
ceptors at the nanoscale creating meso-, micro- and macro-complex
structures that are hierarchically and spatially organized (Lane et al.,
2014; Nakatsuji, 2013). Among the multitude of surface receptors,
cells present super-families of integrins, cadherins, receptor tyrosine ki-
nase, selectins, proteoglycans and immunoglobulins. The type, density
and stability of the consequently activated/co-activated receptors trig-
ger speciﬁc intracellular events deﬁning cell fate at very different ex-
tents, such as: survival, motility, polarity, proliferation, cytoskeleton
organization, cell–cell interactions and gene-expression (Bernﬁeld
et al., 1992; Borghi et al., 2010; Carey, 1997; Choi et al., 2011; Gumbiner,uctions between the construct and the host tissue implying a balanced matrix production
ltiscale instructive tissue engineering constructs: Current approaches
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Table 1
Categories of physicochemical cues in stemcell niches that affect cell behavior, and some examples of extracellular cue–cell receptor interactions (Humphries et al., 2006; Lane et al., 2014).
ICAM, intercellular adhesion molecule; VCAM, vascular cell adhesion molecule.
Cue
category
Ligands/cue Cell receptors/effect
Secreted factors Chemokine Chemokine receptors
Growth factors Tyrosine kinase receptors
Extracellular matrix Fibronectin Integrins α4β1, α4β7, αVβ3, αVβ6, αIIbβ3, ανβ1, α5β1, α8β1.
Collagen Integrins α10β1, α2β1, α1β1, α11β1.
Vitronectin Integrins ανβ5, ανβ3, α8β1, αIIbβ3.
Physical Topography
Stiffness/elasticity
Alters formation of focal adhesion points and cytoskeleton contraction
Hypoxia and metabolic O2 Enters cells by diffusion and participates in metabolic process.
pH Affects proton transport and the function of cell membrane proteins.
Ca2+ Calcium channels/pumps; Ca2+ plays important roles in signaling transduction pathways.
Glucose Glucose transporters; glucose is the main source of energy, among other functions.
Cellular Tissue speciﬁc-cells, stem cells, immune cells,
nerve cells, endothelial cell, stromal cell
Cadherins (N, N2, P, E), ICAM, VCAM, integrins (e.g. αVβ3 with CD31 in endothelial cell)
3S.M. Oliveira et al. / Biotechnology Advances xxx (2015) xxx–xxx1996; Hynes, 2002; Kim et al., 2011; Lemmon and Schlessinger, 2010;
Takeichi, 1991; Ullrich and Schlessinger, 1990).
The nature of the niche is considerer speciﬁc for each stem cell type
and tissue (Gattazzo et al., 2014). Nevertheless, the categories of the en-
vironmental cues inﬂuencing cell behavior are transversal for the tissue,
cell or culture type (in vivo, ex vivo or in vitro)— Table 1. Therefore, un-
derstanding the normal and regenerative (stem) cell niche and tissue
can enlighten and inspire the design of cell instructive biomaterials.
Upon tissue injury, immune cells and others migrate, triggering the
healing cascade or an immune response. The healing cascade consists
of four major integrated and overlapping phases: hemostasis; inﬂam-
mation; proliferation and repair; and tissue remodeling or resolution
— Fig. 2 (Enoch and Leaper, 2008; Gosain and DiPietro, 2004; Guo and
Dipietro, 2010).
The temporary micro/nano-environment of each stage is regulated
by several cell types, matrix proteins, growth factors (GFs) and cyto-
kines— Table 2. Extreme changes are known to happen in the physical,
biochemical, cell–cell communication and extracellular matrix polysac-
charides or protein patterns, during the normal and efﬁcient healing
cascade (Witte and Barbul, 1997). The failure, or prolongation, in one
phasemight result in a delayed or impaired healing. This may be caused
by low stem cell availability, aging, continued activation of inﬂammato-
ry cells, excessive pro-inﬂammatory MMP, excessive proliferation and
matrix synthesis, among others (Forbes and Rosenthal, 2014; Mehta
et al., 2012; Menke et al., 2007; Utz et al., 2010; Witte and Barbul,
1997). The repair process may only restore some of the structures ofa b
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Fig. 2. a) General phases involved in the healing cascade triggered by a tissue injury (based on
et al., 2012). b) Illustration of a cutaneous wound reproduced with permission from Clark et al
phase usually ending with tissue repair or failed healing. Several bioactive factors have mult
factor; TGF, transforming growth factor; PDGF, platelet-derived growth factor; VEGF, vascula
activator; u-PA, urokinase-type plasminogen activator.
Please cite this article as: Oliveira, S.M., et al., Towards the design of 3Dmu
and trends, Biotechnol Adv (2015), http://dx.doi.org/10.1016/j.biotechadvthe original tissue and involve scar formation. Only an adequate balance
between new matrix deposition and matrix degradation, during the
heading, allows a successful regenerated tissue identical to the original
one to be achieved.
An injury causes vascular endothelium disruption, exposing the col-
lagen layer and other elements that activate platelets. Nowadays, plate-
lets are recognized asmajor players in the healing cascade, tissue repair
and regeneration (Anitua et al., 2004; Gawaz and Vogel, 2013; Stellos
et al., 2010) Besides maintaining the blood vessel integrity by adhering,
aggregating and forming a pro-coagulant ﬁbrin surface (hemostasis),
platelets initiate the healing process. Once activated, the substances
released from the platelet's granules (dense granules, lysosomes and
α-granules) are responsible for triggering the healing cascade. For
instance, α-granules contain many instructive GFs, such as: vascular
endothelial growth factor (VEGF), ﬁbroblast growth factor (FGF),
transforming growth factor β, (TGF β), epidermal growth factor (EGF),
platelet derived growth factor (PDGF) and insulin-like growth factor
(IGF). Besides their role in hemostasis, platelets play important anti
and pro-inﬂammatory roles and their releasates also participate in the
other healing stages (Gawaz and Vogel, 2013; Semple et al., 2011;
Sephel and Woodward, 2001; Vieira-de-Abreu et al., 2012; Weyrich
and Zimmerman, 2004; Zarbock et al., 2007). In the early phase, adher-
ent platelets interact with endothelial cells, monocytes and neutrophils.
They activate neutrophils and endothelial cells inducing the production
of inﬂammatory cytokines. Platelets are potent instructive cells, and ac-
tually have been inspiring and used as a source of multiple instructiveEpstein et al., 1999; Mendonca and Coutinho-Netto, 2009; Guo and Dipietro, 2010; Claes
. (2007): top— crosstalk between the clot and the surrounding tissue in the inﬂammatory
iple effects and multiple sources. FGF, ﬁbroblast growth factor; IGF, insulin-like growth
r endothelial growth factor; MMPs, matrix metalloproteinases; t-PA, tissue plasminogen
ltiscale instructive tissue engineering constructs: Current approaches
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Table 2
Major cell types involved on the healing of injured tissues and their respective function and participating phases.
Adapted from Kamath et al. (2001), Sephel and Woodward (2001), Sipe et al. (2004) and Vieira-de-Abreu et al. (2012).
Cell Phase Function
Platelets Hemostasis
Inﬂammation
Repair
Remodeling
Major players in hemostasis. Granules release cytokines, chemokines,
GFs, clotting agents, proteases and inﬂammation mediators. Facilitate adhesion,
coagulation, vasoconstriction, repair and clot resorption. Their activation attracts
and activates several cells
Leukocytes Inﬂammation Granulocytes (neutrophils, basophils, eosinophils) and agranulocytes
(lymphocytes monocytes and macrophages) are immune system cells
involved in the foreign-body reaction. The type of leukocytes recruited
is controlled by the type and concentration of the released chemokines in
the injury place. Granulocytes are recruited from bone marrow within the
ﬁrst day and are responsible for the degradation of unviable tissue releasing
their granule content. For instance, basophils, e.g., release heparin, histamine,
proteases, and chondroitin. Neutrophils can secrete products that stimulate
monocytes and macrophages.
Mast cells Hemostasis Resident cells that contain granules rich in histamine and heparin
Resident cells Hemostasis
Inﬂammation
Repair
Remodeling
Tissue resident cells such as resident macrophages and stem cell release healing
mediators in the early and long-term response
Macrophages Inﬂammation
Repair
Remodeling
Macrophages arrive at the injury site shortly after neutrophils where they
persist for days or longer. Release cytokines, chemokines and GFs. Participate
in the phagocytosis of debris and on the development of granulation tissue
Fibroblast, pericytes,
smooth muscles cells
Inﬂammation
Repair
These cells are recruited by locally released GFs and extracellular matrix
degradation products. In the case of skin, these cells are responsible for matrix synthesis,
wound strength and contraction and tissue remodeling
Endothelial cells Hemostasis
Inﬂammation
Repair
This cells form capillaries upon GF instruction, which are essential for nutrients, gas,
metabolite diffusion and for the inﬂux of inﬂammatory cells
4 S.M. Oliveira et al. / Biotechnology Advances xxx (2015) xxx–xxxproteins for the preparation of new constructs for several tissue-
engineering applications (Lima et al., 2015; Oliveira et al., 2015a,b;
Santo et al., 2012b). Similar to platelets, other cells involved in
the healing cascade play important roles by secreting similar or other
instructive compounds such as the leukocytes and other granulocytes
— Table 2.Table 3
Tissue expression of extracellularmatrixmolecules adapted from Sephel andWoodward (2001)
collagen varies: ﬁbrillar collagens (I, II, III, V, XI), network-forming collagen (IV, VIII, X), non-ﬁ
Tissue or ﬂuid Primary
mesoderm cell
Prominent
collagen types
Noncollagen
proteins
Blood – – Albumin, ﬁbri
globulins
Dermis Fibroblast I, III, V, VI, XII Fibronectin, e
ﬁbrillin
Muscle Muscle cell/ﬁbroblasts I, III, V, VI, VIII, XII Fibronectin, e
ﬁbrillin
Tendon Fibroblast I, III, V, VI, XII Fibronectin, t
(myotendon j
elastin, ﬁbrilli
Ligament Fibroblast I, III, V, VI Fibronectin, e
ﬁbrillin
Cornea Fibroblast I, III, V, VI, XII –
Cartilage Chondrocyte II, IX, VI, VIII, XI, X
(hypertrophic
chondrocytes)
Anchorin CII,
tenascin
Bone Osteocyte,
osteoblasts,
osteoclasts
I, V Osteocalcin, o
bone sialopro
osteonectin
Basement membranes Epithelial, endothelial,
adipocytes, Schwann cell,
muscle cells, pericyte,
ﬁbroblasts
IV, XV, XVIII Laminin, nido
Please cite this article as: Oliveira, S.M., et al., Towards the design of 3Dmu
and trends, Biotechnol Adv (2015), http://dx.doi.org/10.1016/j.biotechadvThe speciﬁc nature of the extracellular matrix of the tissue also reg-
ulates the GFs and other bioactive protein distribution, type, and stabil-
ity (Discher et al., 2009; Kim et al., 2011; Schultz and Wysocki, 2009).
GFs are presented either in soluble form, or mainly electrostatically
bound to the negatively charged glycosaminoglycans (GAGs). GAGs
present variousmolecular arrangements and different sulfation degreesand other extracellular characteristics. According to the type, the structural function of the
brillar collagens (VI, IX, XII, XV, XVIII) and anchoring (VII, XVII).
GAGs and PGs Others
nogen, Hyaluronic acid, sulfated GAGs Red and white blood cells,
platelets, plasma
lastin, Hyaluronic acid, decorin,
biglycan, ﬁbromodulin
Stratiﬁed and vascularized tissue
lastin, Aggrecan, biglycan, decorin,
ﬁbromodulin
Soft tissue with oriented actin and
myosin ﬁlaments
enascin
unction),
n
Decorin, biglycan, ﬁbromodulin,
lumican, versican
Bone–muscle connection.
Mostly collagen
type I forms ﬁber bundles
lastin, Decorin, biglycan, versican Bone–bone connection.
Mostly parallel array of
collagen ﬁbers closely packed
Lumican, keratocan,
mimecan, biglycan, decorin
Avascular and transparent
stratiﬁed tissue
ﬁbronectin, Hyaluronic acid, aggrecan,
biglycan, decorin, ﬁbromodulin,
lumican, perlecan (minor)
Flexible, avascular and ECM
rich in PGs and elastin
steopontin,
tein,
Decorin, ﬁbromodulin, biglycan Rigid and vascularized tissue
containing 50–70% of calcium
phosphate, 20–40% organic
matrix, 5–10% of water and
b3% of lipids. Long bones
contain medullar cavity.
gen/entactin Heparan sulfate,
proteoglycans, perlecan
Nano-stratiﬁed membrane
surrounding cells or
cellular structures
ltiscale instructive tissue engineering constructs: Current approaches
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5S.M. Oliveira et al. / Biotechnology Advances xxx (2015) xxx–xxxand are usually linked to a small protein core, forming proteoglycans
(Kreuger et al., 2006; Nigam and Bush, 2014; Schultz and Wysocki,
2009). Furthermore, the nature of the major cell and protein types
forming the extracellular matrix of the tissues shows certain speciﬁcity,
highlighted in Table 3.
Both the speciﬁc nature of the extracellular matrix and the healing
cascade have been inspiring the development of cell instructive tissue
engineered constructs (Custodio et al., 2014a). Those relevant cues
have been incorporated into biomaterials by: i) the incorporation of
human or recombinant GFs, or analoguesmoieties; ii) the incorporation
of ECM-tissue speciﬁc compounds, or analogues moieties; iii) the use of
co/multi-cultures or cell–cell contact analogues; and iv) the use of im-
munomodulatory biomaterials. The presentation and incorporation of
GFs into biomaterials is commonly controlled by recourse to release
systems or surface modiﬁcation techniques. More translational
developments in this area have been hindered by the high cost of re-
combinant GFs. Thereby, platelet derivatives have attracted immense
attention as a human source of multiple GFs and other bioactive mole-
cules demonstrating hugemitogenic, immunomodulatory and differen-
tiation potential (Andia and Maffulli, 2013; Anitua et al., 2004; Cinotti
et al., 2013; Kassolis et al., 2000; Kim et al., 2014a; Marx et al., 1998;
Oliveira et al., 2015a,b; Semple et al., 2011; Stellos et al., 2010;
Vieira-de-Abreu et al., 2012; Weibrich et al., 2002; Weyrich and
Zimmerman, 2004).
Engraftment of small peptides mimicking the bioactive epitopes of
natural ECM molecules has also shown promising results (Nichol and
Khademhosseini, 2009). Frequently, those moieties play important roles
during the tissue morphogenesis. For example, the peptide with theFig. 3. General 3D construct's features categorized according to their major function and length
biochemical cues.
Please cite this article as: Oliveira, S.M., et al., Towards the design of 3Dmu
and trends, Biotechnol Adv (2015), http://dx.doi.org/10.1016/j.biotechadvsequence of Asp-Gly-Glu-Ala (DGEA), which is derived from collagen
type I, has been shown to induce an early-commitment of humanmesen-
chymal stem cells towards the osteogenic lineage (Anderson et al., 2009;
Mizuno and Kuboki, 2001). The peptide Glu-Glu-Glu (EEE), which is in-
spired in the acidic residues of non-collagenous matrix proteins such as
osteocalcin and osteopontin, has been shown to promote a more mature
osteogenic differentiation than the DGEA (Ceylan et al., 2014).
The combination of different cell types is another approach to obtain
a closer representation of the complex cross-talk that occurs in the nat-
ural tissue (Battiston et al., 2014). The addition of another cell-type pro-
ducer of bioactive factors allows a different scheme of interactions,
promoting paracrine, autocrine routes and cell-contact dependent ef-
fects. Several studies have shown synergistic effects upon the use of
co-culture systems and the capability to induce stem cell differentiation
(Cooke et al., 2011; J. Wang et al., 2011; Schneider et al., 2011).
Biomaterials for immunomodulation are one of the keys to instruct
cell behavior upon implantation and promote the long-term functional-
ity of the device (Forbes and Rosenthal, 2014; Franz et al., 2011;
Mokarram and Bellamkonda, 2014). The surgical procedure always
initiates an inﬂammatory response and may elicit an adaptive immune
reaction towards the construct surface that should be controlled. Immu-
nomodulatory biomaterials allow the control of the tissue response at
the implant site regarding primarily cell adhesion and/or cellular activa-
tions. An indirectmodulation controls immune cell adhesion and activa-
tion, consequently indirectly inducing speciﬁc GF secretion. On the
other hand, on a direct approach, speciﬁc singlingmolecules are includ-
ed in the biomaterial (Franz et al., 2011). Controlling hydrophilicity
(Jones et al., 2007; Song and Mano, 2013) and fouling propertiesscale-range: geometry, cell-anchorage, release system, cellularity, topographical cues and
ltiscale instructive tissue engineering constructs: Current approaches
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6 S.M. Oliveira et al. / Biotechnology Advances xxx (2015) xxx–xxx(Zhang et al., 2013), topography/roughness (Fink et al., 2008; Yim and
Leong, 2005), adhesion sites (e.g., RGD) (Kao and Lee, 2001; Kao and
Liu, 2001), incorporation of anti-inﬂammatory mediators (Hetrick
et al., 2007; Makrydima et al., 2014), self-protein inhibitors (Kim et al.,
2014b) and GFs (Caridade et al., 2015; Kehrl et al., 1986; P.M. Chen
et al., 2014; Patil et al., 2007), and the use of cells with immunomodula-
tory properties (Hanson et al., 2014; Singer and Caplan, 2011) are the
common applied strategies.
Currently it is technically limitative to fully reconstruct the whole
complexity and nature of the healing/regeneration events into a
tissue-engineered 3D substrate. Selecting some key events/components
of the tissue formation/healing or late-stages may be an efﬁcient
approach to drive the formation of tissue constructs. The balanced
incorporation of those keys or their bioinspired cues (e.g. epitopes)
onto constructs may guide and instruct tissue-speciﬁc cell behavior
and modulate the healing cascade and immune response.
3. Multiscale construct design features
Designing the construct features for in vitro cell fate control and, si-
multaneous, adequate in vivo performance, is one of the main focuses
in tissue engineering (Alves et al., 2010; Lutolf et al., 2009; Marklein
and Burdick, 2010). According to the processing approach used for the
structure preparation, the best scale working range varies: top-down
approaches are more adequate for macro–micro-scale and bottom-up
approaches allow higher micro–nano-scale control, while full scale
rangemight be controlled using integrative approaches. Thereby, differ-
ent approaches offer different control degrees on the ﬁnal properties of
the scaffolds. Nonetheless, multiple variables must be considered, inde-
pendent of the processing approach. Besides the mechanical properties
and the immune reaction, the type and spatial–temporal distribution of
the device properties will guide and instruct cell behavior, namely: cell
adhesion, cell viability, proliferation, differentiation, matrix production
and degradation. According to their major function and scale range,
the general scaffold design features can be arbitrarily categorized as:
i) geometry; ii) cell-anchorage; iii) release-system; iv) cellularity;
v) topographical cues; and vi) biochemical cues — Fig. 3. The scale def-
inition considered is: macro (N10 mm), sub-macro (100 μm–10 mm),
micro (1 μm–100 μm), sub-micro or meso (100 nm–1 μm), and nano
(b100 nm).
3.1. Geometry —macro, sub-macro
The geometry of the scaffold has, generally, to be tailored according
to the implantation site request, in order to ﬁll the tissue's void space
and support the site's mechanical demands. Additive (Hutmacher
et al., 2004; Melchels et al., 2012; Tsang et al., 2007), ablation (Meng
et al., 2009) and molding (C.H. Chen et al., 2014; Correlo et al., 2009;
Zhang et al., 2014) technologies, based on previous three dimensional
patient data acquisition (e.g., by X-ray microtomography or magnetic
resonance imaging), allow the preparation of geometry-speciﬁc 3D
structures. On the other hand, someapplicationsdonot demand speciﬁc
geometries or high mechanical strength. In such cases, combinations of
materials, cells and bioactive factors are usually injected ﬁlling the void
spaces (Custodio et al., 2015; Custódio et al., 2014; Koshy et al., 2014;
Kretlow et al., 2007; Larsson and Hannink, 2011). Shaping the material
frequently affects the bulk mechanical properties of the construct. For
instance, scaffolds prepared by rapid prototyping show different com-
pression moduli according to the alignment (Hutmacher et al., 2001)
or the distance between struts (Sobral et al., 2011). Nonetheless, com-
puter assisted design technologies offer the possibility to simulate and
optimize the inner geometry (strut alignment, pore size, pore geometry
and interconnectivity) in order to enhance the mechanical perfor-
mance, by using ﬁnite element analysis and CAD design tools (Lacroix
et al., 2006; Lin et al., 2004; Sandino et al., 2008). Those micro-features,
pore geometry (Bidan et al., 2013; Rumpler et al., 2008), pore size (OhPlease cite this article as: Oliveira, S.M., et al., Towards the design of 3Dmu
and trends, Biotechnol Adv (2015), http://dx.doi.org/10.1016/j.biotechadvet al., 2007; Woodﬁeld et al., 2005; Zeltinger et al., 2001) and porosity
(Karageorgiou and Kaplan, 2005), also affect oxygen perfusion, the re-
moval of cell metabolites, cell seeding efﬁciency and tissue growth
rate, making them very important features regarding cell viability and
growth. Additionally, thosemicro-properties also inﬂuence the invasion
of inﬂammatory and immune cells and the ingrowth of blood vessels or
other cells from the host tissue (Karageorgiou and Kaplan, 2005; Karp
et al., 2004; Kasten et al., 2008).
3.2. Cell-anchorage — sub-macro, micro, sub-micro, nano
The cell-anchorage deﬁnes the physical elements supporting
the adhesion of the cells at scale smaller than the geometry of the scaf-
fold. Depending on the technique used to shape thematerials or, e.g., de-
pending on the subsequent/simultaneous incorporation of gels (Correia
et al., 2012; Prabaharan et al., 2007b), sponges (Chen et al., 2003; Mano
et al., 2008), micro/nano-ﬁbers or ﬁbrillar structures (S.M. Oliveira et al.,
2013b), the anchorage points and the micro-properties of the scaffold
can be tailored. Introducing anchorage points within the pores is also
a way to increase cell surface growth area/volume and alter the spatial
distribution of the tissue growth. Moreover, their physical properties
(e.g. stiffness/elasticity and adhesion area) will affect cell morphology
by altering the cytoskeletal organization and contractibility, which can
guide stem cell differentiation into speciﬁc lineages (Engler et al.,
2006; Guilak et al., 2009).
3.3. Release systems —micro, sub-micro, nano
The incorporation of release systems in the substrates is considered
an essential tool for the temporal or spatial–temporal controlled delivery
of instructive or pharmaceutical compounds (Lima et al., 2012; Madduri
and Gander, 2012; Oliveira and Mano, 2011; Santo et al., 2012c, 2013).
Some examples of release systems of interest in tissue engineering relate
to the delivery of one or multiple compounds such as GFs (Johnson and
Wang, 2013; Kim et al., 2013; Richardson et al., 2001; Tabata, 2003),
dexamethasone (Duarte et al., 2009a;Wang et al., 2010, 2014), gentami-
cin (Gao et al., 2011; Li and Chang, 2005), ketoprofen (Prabaharan and
Mano, 2005; Prabaharan et al., 2007a) and platelet derivatives
(Coppinger et al., 2004; Kawase et al., 2003; Santo et al., 2012a; Y.K.
Kim et al., 2014). Typically, a release-system can be prepared by the
solemixing of the compoundswith thematerials prior to the 3Dprocess-
ing (Perets et al., 2003; Santo et al., 2012a), or by its incorporation after-
wards, using surface modiﬁcation techniques (e.g., by layer-by-layer
assembling (Gilde et al., 2012) or adsorption (Santo et al., 2012b)) or im-
pregnation (e.g. supercritical ﬂuid CO2 (Cabezas et al., 2014; Biondi et al.,
2008)). In combination with stimuli responsive materials (Mano, 2008),
these systems can be triggered in a controlled manner, for instance by
temperature (Costa et al., 2009; Shi et al., 2008), pH (Costa et al., 2009;
Santos et al., 2010) and light stimuli (Borges et al., 2014; Mano, 2008;
Stuart et al., 2010). Besides being interesting for the development of
smart release systems, stimuli responsive materials have been shown
to provide variations in other important properties, such as wettability,
affecting cell adhesion (da Silva et al., 2007) or mineralization
(Cole et al., 2009; Shi et al., 2007).
3.4. Cellularity —micro
For cellular tissue engineered approaches, the type of cells seeded on
the 3D structure has major percussions on new tissue formation. Ac-
cording to the source tissue or donor, stem cells possess different differ-
entiation potentials (Bianco et al., 2001; Chamberlain et al., 2007; Kern
et al., 2006; Odorico et al., 2001). Moreover, the seeding of more than
one cell type (i.e. co/multiple cell culture) and the ratio between those
cells allows different crosstalk to occur. The presence of other cells
will affect the nano/micro-environment, e.g., by creating a new proﬁle
of cell-secreted cytokines and GFs (Cooke et al., 2011; Schneider et al.,ltiscale instructive tissue engineering constructs: Current approaches
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ty can affect cell growth (Dar et al., 2002; Rodriguez et al., 2001; Wen‐
tao et al., 2006) and differentiation (Bitar et al., 2008; Lee and Hu,
2013; Masur et al., 1996; Poumay and Pittelkow, 1995).
3.5. Topographical cues —micro, sub-micro, nano
The nano/micro-topographical cues are one of the primary media-
tors of the adsorption of proteins, from the surrounding media (e.g.,
serummedia or plasma), that further mediate the cell adhesion process
(Lord et al., 2010; Raffaini and Ganazzoli, 2013; Roach et al., 2006; S.M.
Oliveira et al., 2014; Song and Mano, 2013). Controlling these features
can synergistically improve cell behavior. As it has been shown, design-
ing speciﬁc surface grooves and patterns can induce speciﬁc cell shapes
(Chou et al., 1995; McBeath et al., 2004; Singhvi et al., 1994) or align-
ments (Hosseini et al., 2014; Lucker et al., 2014; McCloskey, 2013)
that alter cytoskeleton contractibility guiding cell differentiation. Well-
controlled topographical cues, patterns and surface biochemistries can
be easily prepared in 2D. However, the transposition of those features
to 3D is still amajor challenge. Surface properties design and surface en-
gineering techniques have been extensively reviewed elsewhere (Alves
et al., 2010; Brafman, 2013; Costa andMano, 2014; Discher et al., 2009;
Dvir et al., 2011; Han et al., 2014; Lutolf and Hubbell, 2005; Lutolf et al.,
2009; Marklein and Burdick, 2010).
3.6. Biochemical cues — nano
At the nanoscale, the surface biochemistry instructs cell behavior ei-
ther by directlymediating the adsorption of surrounding proteins to the
construct, or by binding/activating cell surface receptors — Table 1. The
biochemical cues, such as GFs (Gitay-Goren et al., 1992; King and
Krebsbach, 2012; Saik et al., 2011), extracellular matrix proteins
(Custodio et al., 2010; Sayyar et al., 2014; van den Dolder et al., 2003;
Zhang et al., 2005) (e.g., collagen and ﬁbronectin), functional groups
(Amorim et al., 2013; Arima and Iwata, 2007; da Costa et al., 2012)
(e.g. sulfation (S.M. Oliveira et al., 2013a)), small peptides (Hersel
et al., 2003; Massia and Hubbell, 1990, 1991) (e.g., -RGD), and cell con-
tacts (Chen et al., 2004; Lambert et al., 2000) (e.g., cell–cell interactions
or functional groups mimicking cells contact) will trigger speciﬁc sin-
gling pathways in the cell and deﬁne their fate. A controlled design of
the biochemistry is commonly made recurring to nanotechnologies
and surface modiﬁcation methods, such as: layer-by-layer assembling
(Jan and Kotov, 2007; Macdonald et al., 2011; Martins et al., 2010;
Neto et al., 2014; S.M. Oliveira et al., 2013a) and antibody mediated
binding (Custodio et al., 2014b; Custódio et al., 2014).
Despite most features might be roughly allocated to a deﬁned
range of length scale, their properties can be intimately related
with other features (S.M. Oliveira et al., 2014). A classical example
is the case of roughness–wettability (Neto et al., 2011; S.M. Oliveira
et al., 2011, 2014). Introducing nano/micro-roughness in a substrate
in the ﬁrst instance may represent a higher surface area available for
cell growth. Nevertheless, the altered roughness might also change
the surface wettability into values that are not as favorable for cell
adhesion/growth (Alves et al., 2009; Song et al., 2009). Whether
the ability of a surface to be wet is altered, its proﬁle of protein ad-
sorption will also change in terms of conformation and density of
proteins. Consequently, the communication between cell and the
support can be signiﬁcantly altered at the cell receptor level
(Gittens et al., 2014).
4. Differentiation biases and aging
Regenerative success is intricately dependent on all the interactions
that cells are subjected to upon the in vitro culture, the interaction with
the construct and the in vivo implantation. Besides the crucial roles of
the biomaterials' properties considered in most of the researchPlease cite this article as: Oliveira, S.M., et al., Towards the design of 3Dmu
and trends, Biotechnol Adv (2015), http://dx.doi.org/10.1016/j.biotechadvconducted in tissue engineering explored in the last section, there are
others affecting mostly the cellular phenotype and genotype quality.
Those features concern issues such as cell senescence, aging and differ-
entiation biases.
Most of the commonly used in vitro expansion platforms are not
adequate and damage cell telomeres, causing cell senescence,
aging, reduction of differentiation potential and differentiation
biases (Haik et al., 2000; Oh et al., 2014; Salehinejad et al., 2013).
The conditions used for stem cell expansion can alter the lineage
fate. Moreover, it has been reported that stem cells have mechanical
memory of previous culture conditions (Yang et al., 2014). Also, it
has been shown that the chemistry of the surface used to expand
stem cells does affect their in vivo regeneration capability (Huang
et al., 2014), as well as the tendency for a certain lineage differentia-
tion (Hsu and Huang, 2013). For instance, the biases lineage-
commitment tendency of mesenchymal stem cells to undergo
aging, telomere shortening, and spontaneous low quality osteogenic
differentiation upon regular culture expansion, as well as decreased
multilineage differentiation quality has been reported (Li et al.,
2011; Yang et al., 2014). To overcome those issues, geometrical, to-
pographical and physical cues can be used to alter cytoskeleton con-
tractibility, guiding stem cell lineage speciﬁcation, and reducing the
biases as well as telomerase activator can be incorporated in order
to delay telomeres shortening (Engler et al., 2006; Guilak et al.,
2009; Kilian et al., 2010; Reilly and Engler, 2010). There is still an ur-
gent need to develop and spread anti-aging, anti-biases procedures,
and new 2D/3D expansion substrates to improve speciﬁcity, cellular
performance and tissue regeneration.
5. Approaches for 3D construct fabrication
3D constructs can be prepared using top-down, bottom-up or in-
tegrative methodologies. Those approaches allow varied length scale
degrees of control of the building and ﬁnal properties. Using top-
down approaches, well-deﬁned scaffolds, where multiscale control
is not a demand, can be prepared, whereas bottom-up stands for a
higher control at the nano/micro scale. On the other hand, integra-
tive approaches emerge as a combination of both top-down and
bottom-up approaches, promising scaffolds with properties and fea-
tures controlled over the entire scale range. Bottom-up and integra-
tive approaches present higher potential for the design of supportive
biomaterials with multiscale features and high biochemistry control
than top-down, being more focused in this review.
5.1. Top-down approach
Top-down approaches provide considerable higher control over the
macro/micro scale properties/features rather than the nano/sub-micro
ones. A bulk material is scaled down into small compartments or nano-
scale details are incorporated, indirectly controlling the processing pa-
rameters of the fabrication technique (Yan et al., 2011). Top-down
scaffolds have been produced recurring to several processing tech-
niques, such as: freeze-drying (Correia et al., 2011; Ho et al., 2004; Wu
et al., 2010), solvent-casting (Mota et al., 2012; S.S. Silva et al., 2013;
Sin et al., 2010; Thadavirul et al., 2014), electrospinning (Park et al.,
2008; Yoshimoto et al., 2003; Zong et al., 2005), rapid prototyping
(Landers et al., 2002; Silva et al., 2009; Yang et al., 2002) and supercrit-
ical ﬂuids (Duarte et al., 2009b, 2012). They present pores andmechan-
ical properties that can be controlled to some extent, for instance, by
controlling the inner architecture and the nature of the materials. In
particular, rapid prototyping allows a precise and computer assisted de-
sign of the inner geometry and, simultaneous, control of the external
shape. All different kinds of materials and blends, including natural
and synthetic polymers and proteins, ceramics and metals, have been
used to prepare 3D constructs. With exception of extracellular derived
compounds or moieties that not always are obtained from cost-ltiscale instructive tissue engineering constructs: Current approaches
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Fig. 4. Current strategies employed for the bottom-up assembling of small units: random, mediated and speciﬁc.
8 S.M. Oliveira et al. / Biotechnology Advances xxx (2015) xxx–xxxeffective sources, those constructs frequently lack cell instructive cues
(Silva et al., 2010). To improve cell behavior on such structures, usually
the scaffolds are prepared combining different top-down techniques
(W. Wang et al., 2011; Yeo and Kim, 2014) or are subjected to further
functionalization requiring integrative approaches (Macdonald et al.,
2011; S.M. Oliveira et al., 2013b; Yeo and Kim, 2011). For instance,
electrospinning and 3D printing can be combined to prepare hierarchi-
cal scaffolds with dual scale ﬁbers: the printed micro-struts combined
with electrospun nano/microﬁbers (Park et al., 2008; Santos et al.,
2008; Tuzlakoglu et al., 2005). The electrospun ﬁbers increase cell-
anchorage points and seeding efﬁciency (Park et al., 2008) and can pro-
mote cell alignment (Park et al., 2014).
5.2. Bottom-up approach
Bottom-up methodologies are those applying chemical or physical
forces leading to the assembling of micro/nanoscopic-deﬁned building
blocks into larger scale structures. The chance to control the construct
over several length-scales makes this approach more attractive for ma-
trices' engineering than the top-down approach, namely in ﬁnding new
opportunities tomimic a tissuemicrostructure and the spatial organiza-
tion ofmultiple cell types (Nichol and Khademhosseini, 2009). Themost
commonly used building blocks comprise cells, cell aggregates/spher-
oids, nano/microparticles, tubes, layers, ﬁbers and gels. The develop-
ment of methodologies to produce, functionalize, and assemble those
small units is the major challenge — Fig. 4. Currently, there are three
general alternatives to assemble the units: i) randomly; ii) mediated
by an external force; and iii) speciﬁcally assembled — see Fig. 4.
5.2.1. Random assembling
Layer-by-layer assembling (LbL) is a simple and random bottom-up
assembling method based on the alternated deposition ofPlease cite this article as: Oliveira, S.M., et al., Towards the design of 3Dmu
and trends, Biotechnol Adv (2015), http://dx.doi.org/10.1016/j.biotechadvpolyelectrolytes with different charges (Borges and Mano, 2014; S.M.
Oliveira et al., 2013a; Tang et al., 2006). Using LbL, multilayered struc-
tures can be created around the units, binding and stabilizing the entire
set and forming a scaffold (Miranda et al., 2011; Sher et al., 2015a,b),
temporary templates to produce high porous foams (J.M. Silva et al.,
2013; Sher et al., 2010) or hierarchical capsules (Correia et al., 2013;
Costa et al., 2013). Such extension of the LbL methodology towards
the fabrication of 3D structures is an example of the application of this
technology in the biomedical ﬁeld (Costa and Mano, 2014).
It has also been shown that the building blocks can be unspeciﬁcally
assembled by cells which colonize their surfaces, consolidating the
structure (García Cruz et al., 2008; M. B. Oliveira et al., 2011; McGuigan
and Sefton, 2006). The presentation of cell-recognizable moieties on
the surface can accelerate this cell-based assembling. For instance, chito-
san microparticles functionalized with a mitogenic GF (PDGF) have
shown a stable and faster assembling, within 12 h, than in the absence
of PDGF (Custódio et al., 2014).
Scaffold free technologies represent another derivation of the
bottom-up approach. Cells grown on thermoresponsive culture dishes
are retrieved as a conﬂuentmonolayer, containing the extracellularma-
trix proteins, by decreasing the local temperature (da Silva et al., 2007;
Yang et al., 2005, 2007). These cell sheets can be consecutively stacked
on top of each other to produce thicker andmore complex tissues. A re-
ported alternative is based on consecutive cell seeding on top of conﬂu-
ent cell layers previously coated with proteins (Chetprayoon et al.,
2013; Matsusaki, 2012). The preparation of thick cell-constructs and
their low load-bearing capability are the major challenges in using
such technology in tissue engineering.
5.2.2. Mediated assembling
The assembling of small units can be guided by external stimuli,
allowing the control over their spatial organization to a certain extent.ltiscale instructive tissue engineering constructs: Current approaches
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Fig. 5. Different integrative approaches for the preparation of 3D constructs: sequential, integration by combination and technical integration.
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strated using silica particles (Abe et al., 2014a,b; Tamagawa and
Takahashi, 2008). Through electrostatic interactions at the particle–gel
interface and cohesion forces in the particle layer, two gel-surfaces can
be attached. The adhesion force, mediated by the particles, can reach
20 kPa as opposed to 1.5 kPa when using an oppositely charged poly-
electrolyte solution (Abe et al., 2014a,b; Tamagawa and Takahashi,
2008). Hydrogel units composed of materials presenting opposite
charges can also be assembled by electrostatic attractions (Katayama
et al., 2013). However, to promote the electrostatic binding, the distance
among the units has to be decreased, e.g. by direct positioning (Abe
et al., 2014b), by shaking (Katayama et al., 2013) or using acoustic
waves (Xu et al., 2011a). Alternatively, it has been shown that template
gels can be successively dipped onto oppositely charged micro-gel col-
loid to form multilayered-like constructs (Han et al., 2013). Moreover,
the use of shape complementary building blocks allows the formation
of lock-and-key shaped assemblies mediated by electrostatic interac-
tion or surface tension (Du et al., 2008; Katayama et al., 2013). In alter-
native, magnetic nanoparticles can be incorporated into cells (Castro
and Mano, 2013; Souza et al., 2010) and biomaterial units (Gil and
Mano, 2014; Liu et al., 2014; Xu et al., 2011b) and further 3D organized
recurring to an external magnetic ﬁeld. However, until now a perfect
control of the position in the space of the different unit has been limited.5.2.3. Speciﬁc assembling
While the alternatives for the unspeciﬁc 3D assembling of building
block are many, the current available methods to design 3D constructs
with speciﬁc spatial organizations are yet limited and more complex.
Microﬂuidic technologies have been proposing promising tools for
the assembly, for example, of small gel unitsmostly bymediated assem-
bling. By controlling the inlets, outlets and ﬂow, some microﬂuidic de-
vices can actually guide the assembling of small units into 1D, 2D and
3D structures (Chung et al., 2011). Moreover, it has been shown that
using the so-called multilayer-microﬂuidic devices, mosaic hydrogels
with a well-deﬁned spatial composition of materials, cells or pores can
be prepared (Leng et al., 2012).
Based on the oligonucleotide pairs complementarity principle, gel
interfaces can be speciﬁcally assembled (Deschner et al., 2014;
Qi et al., 2013). Setting the spatial/surface presentation of the comple-
mentary sequences in the different units allows the formation of
controlled assemblies. Although being assemble-speciﬁc, this approach
might be scale-up limitative. Other alternative methods, for both mate-
rials and cell controlled assembling, are based on bioprinting technolo-
gies. Bioprinting is a particular type of rapid prototyping technique that
deposits small units of multiple materials and cells, instead of continu-
ous ﬁlaments (Schuurman et al., 2011). Highly complex organizationPlease cite this article as: Oliveira, S.M., et al., Towards the design of 3Dmu
and trends, Biotechnol Adv (2015), http://dx.doi.org/10.1016/j.biotechadvwith cellular vascular networks, multiple cell types and extracellular
matrices were already shown to be achievable (Kolesky et al., 2014).
Even though bottom-up approaches seem ideal to mimic a tissue
organization, major developments and new concepts to improve the
assembling and spatial organization of the assembling units still neces-
sary. Limitations such as theweak control on theﬁnal 3D shape, the lack
of scalability and the lack of understanding on the short and long-term
interactions among the units and cell behavior are yet to be further
investigated.
5.3. Integrative approach
The combination of the top-down and bottom-up approaches
constitutes a valuable strategy to increase the functionality of the
devices for tissue engineering and achieve a multiscale control over
the 3D substrate properties.
According to the integration between the bottom-up and top-down
approaches, three sub-categories of integrativemethods can bedeﬁned:
i) sequential integration; ii) combination; and iii) technical integration
— Fig. 5.
Employing an integrative approach could allow the increment of one
ormore feature/property in the scaffold without impairing the previous
structure properties (Hollister and Murphy, 2011). Thereby, fully
customizable constructs with multiple scales of complexity could be
designed. With such ideal control and the increment of measurable
properties, in silico modulation could contribute greatly for the
understanding of the relationship between multiscale properties and
cell behavior. Those resulting models would allow the mathematical
prediction of cell behavior, contributing to the device optimization
and eventually to the reduction of in vitro/in vivo experimentation
costs (Walpole et al., 2013).
5.3.1. Sequential integration
3D constructs may be prepared using different techniques in a step-
wisemanner; i.e., by sequential integration. In these cases, the 3D struc-
tures are step-by-step prepared using at least one top-down and one
bottom-up method. This category is the most used to overcome the
lack of bioactivity and cell instruction of the traditional 3D scaffolds pre-
pared by top-down approaches. Modiﬁcation techniques such as ad-
sorption, layer-by-layer assembling, self-assembling and grafting can
be used to modify 3D scaffolds without impairing their initial features.
Thosemethods have been used to include instructive cues such as adhe-
sive proteins (Assmann et al., 2013; Choi et al., 2013; Ragetly et al.,
2010; Truong et al., 2012), GFs (Crouzier et al., 2011; Macdonald et al.,
2011; Shah et al., 2014; Tang et al., 2013), modular peptides (Lee
et al., 2009) and bioactive calcium phosphate particles (Zhou et al.,
2014). Controlling the biochemical environment and the incorporationltiscale instructive tissue engineering constructs: Current approaches
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it is yet challenging to control the topographical cues on 3D top-down
structures. The use of microfabrication techniques for the preparation
ofmicro-layers of the substrate is an appealing solution. Several features
might be controlled in each layer (biochemistry, topography, release
system and cells), which are further assembled or stacked (Kolewe
et al., 2013; Lima et al., 2014b). However, assembling and stabilizing
those layers are still challenging as in the case of the bottom-up
approaches.5.3.2. Combination
Contrary to the other categories, in the integration by combination,
the building blocks are incorporated prior to the processing and the
top-down method is performed as if in absence of such units. Thereby,
this approach allows the incorporation of new features, such as release
systems in the bulk structure of the constructs. For instance, supercriti-
cal CO2 ﬂuid foaming was used to prepare scaffolds of poly-L-lactic acid
with nanoparticles carrying platelet lysate (Santo et al., 2012a). The in-
corporation of those bioactive nanoparticles enhanced the osteogenic
differentiation of human adipose derived stem cells on the foams.
Polymeric microcarriers, which allow a controlled expansion and for-
mation of cellular aggregates, were successfully combined with gelatin
methacrylamide–gellan gum bio-inks (Levato et al., 2014). With this
combination, 3D scaffolds could be achieved with simultaneous high
cell density, viability and improved mechanical performance.5.3.3. Technical integration
The technical integration refers to the development of 3D constructs
recurring to specialized equipment for simultaneous top-down and
bottom-up processing. With such type of equipment's, topography, re-
lease system, biochemistry, shape and cells could be ideally controlled.
A foreseen example employing this approach could be the combina-
tion of rapid prototyping and spraying of small-units containing instruc-
tive or topographical cues. Recurring to a software-assisted deposition
of both, shape controlled scaffolds with spatially deﬁned topography,
release systems and biochemistry could be fabricated. Though very ap-
pealing, such sophisticated technologies have yet to be developed.6. Conclusions and perspectives
The major nano/micro-environment properties and events occur-
ring in the normal and regenerative tissue have been inspiring the selec-
tion or synthesis of instructive cues to include in the 3D structures.
However, there is still a need to understandwhich are themost effective
spatial–temporal cues for each tissue. Besides the biochemistry, other
scaffold features, e.g. topography, cells, cell anchorage and geometry,
play major roles for the construct success both in vitro and in vivo.
High-content screening of 3D scaffold properties and features promises
a huge contribute in deciphering which cues, materials and methods
will be more effective for the regeneration of each tissue (Hook et al.,
2010; M.B. Oliveira et al., 2013, 2014; Simon and Lin-Gibson, 2011).
The control of all such features calls for processing approaches that
allow a multiple scale control, i.e., integrative approaches. According to
the combinations between the top-down and bottom-up techniques,
different integrative approaches were deﬁned: sequential, combination
and technical integration. The assembling of building blocks in a single
bottom-up approach is yet in its infancy, in regard to tissue engineering
applications or the development of 3D tissue-models. However, their in-
tegration with top-down approaches, e.g. 3D printing, may accelerate
their development and the preparation of a highly controlledmultiscale
3D tissue engineering devices. The increase in complexity of the fabri-
cated devices should also be balanced with the regulatory issues and
commercial viability so that their realistic employment in the clinics
could be envisaged.Please cite this article as: Oliveira, S.M., et al., Towards the design of 3Dmu
and trends, Biotechnol Adv (2015), http://dx.doi.org/10.1016/j.biotechadvAcknowledgments
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